China Medical System Holdings Limited

Research China Medical System Holdings Limited (2M7C) on Bullrun: market cap EUR 2.65B, P/E 13.6, dividend yield 3.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker2M7C
• ExchangeF
• CountryHong Kong
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 2.65B
• P/E13.6
• Dividend yield3.3%
• Financial periodFY2025
• RevenueEUR 8.21B
• Revenue growth9.9%
• Net incomeEUR 1.49B
• Free cash flowEUR 244.01M
• Gross margin71.5%

Valuation Snapshot

latest market cap is EUR 2.65B; P/E is 13.6; dividend yield is 3.3%.

About China Medical System Holdings Limited

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension;

Frequently asked questions

What is China Medical System Holdings Limited's market cap?

China Medical System Holdings Limited's market capitalization is EUR 2.65B.

What is China Medical System Holdings Limited's P/E ratio?

China Medical System Holdings Limited's price-to-earnings (P/E) ratio is 13.6.

Does China Medical System Holdings Limited pay a dividend?

China Medical System Holdings Limited has a dividend yield of 3.3%.

What does China Medical System Holdings Limited do?

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China.